See our test panels Start drug testing today Could urine drug testing be a good fit for your company? We can answer your questions, provide resources or get an account set up. Get started
Centralize drug testing to optimize efficiency, spend, and patient care For health systems, controlling costs and ensuring accurate patient test history can be challenging. This is especially true when multiple providers—primary care providers, pain specialists, etc—are involved in caring for a patie...
The Quest Diagnostics Drug Testing Index™ (DTI) is a series of reports that provide insights into trends in workforce drug use based on positivity rates of deidentified laboratory tests performed by Quest Diagnostics for a range of illicit, legal and
Quest Diagnostics Business leaders Employers Drug screening Drug Screening Knowledge Center & Tools Knowledge centerKnowledge center for drug testing Regardless of your tenure or experience with workplace drug testing, it can sometimes be a challenge to maintain your proficiency. We strive to provide ...
Drug misuse often occurs unintentionally in any population, which is why Quest Diagnostics offer a broad array of drug testing for your diverse needs.
Diagnostics information services Clinical trials Healthcare IT Risk management Employer population health Drug Screening Read more aboutproducts and services. Operations Headquarters in the U.S.: 500 Plaza Drive, Secaucus, New Jersey 07094 Approximately 2,000 patient locations and dozens of clinical labor...
The article reports on the sale of the rights to royalties by the chemical firm Quest Diagnostics Inc. on the anticancer drug candidate ibrutinib to Royalty Pharma for 485 million dollars as of July 29, 2013 and informs that it had already sold the diagnostics firms OralDNA and HemoCue.A....
SOURCE Quest Diagnostics Europe MORE ON THIS TOPIC Radiopharmaceuticals Sanofi Inks $326M Radiopharma Deal With Orano October 17, 2024 · 2 min read · Tristan Manalac Obesity Lilly’s Sprawling Obesity Clinical Program Underscores...
" said Carrie Eglinton Manner, senior vice president, Advanced Diagnostics, Quest Diagnostics. "Quest and Blueprint Genetics are working together to bring innovative advanced diagnostics – from test ordering to gene variant interpretation and clinical reporting – to patient populations with unmet ...
Quest Diagnostics Inc (NYSE: DGX) Q1 2021 earnings call ended Apr. 22, 2021 Corporate Participants: Shawn Bevec -- Vice President of Investor Relations Stephen H. Rusckowski -- Chairman, Chief Executive Officer and President Mark J. Guinan -- Executive V